Loan Payable and Warrant Liability - Textual (Details)				1 Months Ended	3 Months Ended		6 Months Ended
	Feb. 28, 2024 USD ($) shares	Mar. 10, 2023 USD ($) shares	Jun. 15, 2022 USD ($) Tranche	Mar. 31, 2023 USD ($)	Mar. 31, 2024 USD ($)	Mar. 31, 2023 USD ($)	Jun. 30, 2024 USD ($) $ / shares shares	Jun. 30, 2023 USD ($)	Aug. 31, 2024 $ / shares	Dec. 31, 2023 $ / shares
Debt Instrument [Line Items]
Proceeds from term loan							$ 10,000,000	$ 15,000,000
Amortization of debt issuance costs and discount							$ 269,000	212,000
Common stock, par value (in dollars per share) | $ / shares							$ 0.0001		$ 0.0001	$ 0.0001
Additional warrants to purchase shares	$ 431,000	$ 330,000			$ 431,000	$ 330,000
Fair value change in warrant liability							$ 487,000	$ 110,000
Hercules
Debt Instrument [Line Items]
Issued warrants to purchase shares of common stock | shares	18,359	9,180
Loan Agreement
Debt Instrument [Line Items]
End of term charge of outstanding principal balance, in percentage			5.85%
Amortization of debt issuance costs and discount			$ 2,048,000
Issued warrants to purchase shares of common stock | shares							36,718
Recognized initial warrants at relative fair value							$ 227,000
Loan Agreement | First Twelve Months After Closing
Debt Instrument [Line Items]
Percentage of prepayment charge of outstanding principal balance			2.00%
Loan Agreement | Thereafter
Debt Instrument [Line Items]
Percentage of prepayment charge of outstanding principal balance			1.00%
Loan Agreement | Hercules
Debt Instrument [Line Items]
Proceeds from term loan	$ 10,000,000	$ 15,000,000
Loan Agreement | Term Loan | Hercules
Debt Instrument [Line Items]
Maximum borrowing capacity			$ 150,000,000
Number of tranches available for loan | Tranche			5
Proceeds from term loan			$ 10,000,000
Term loan, description							Under the terms of the Loan Agreement, the Company received $10,000 upon closing, $15,000 was borrowed in March 2023 and an additional $10,000 was borrowed in connection with the second amendment on February 28, 2024 (the “Tranche I and Tranche II Commitments”). At the sole discretion of the Company, $30,000 is available to be drawn from June 15, 2024 through June 15, 2025 (“Tranche III Commitment”). Also at the sole discretion of the Company, an additional $35,000 is available to be drawn at the earlier of the full draw of Tranche III or June 15, 2025 through June 15, 2026 (“Tranche IV Commitment”). An additional $50,000 may become available to the Company prior to January 1, 2026, subject to Hercules' approval (“Tranche V Commitment”).
Maturity date			Mar. 01, 2027
Variable annual rate			7.65%
Issued warrants to purchase shares of common stock | shares							211,137
Loan Agreement | Term Loan | Hercules | Prime Rate
Debt Instrument [Line Items]
Variable annual rate			3.65%
Loan Agreement | Term Loan First Tranche | Hercules
Debt Instrument [Line Items]
Proceeds from term loan	$ 10,000,000	$ 15,000,000		$ 15,000,000
Loan Agreement | Term Loan Second Tranche | Hercules
Debt Instrument [Line Items]
Maximum borrowing capacity			$ 10,000,000
Loan Agreement | Term Loan Third Tranche | Hercules | June 15, 2024 through June 15, 2025
Debt Instrument [Line Items]
Amount available to drawn			$ 30,000,000
Borrowing available start date			Jun. 15, 2024
Borrowing available end date			Jun. 15, 2025
Loan Agreement | Term Loan Fourth Tranche | Hercules | June 15, 2025 through June 15, 2026
Debt Instrument [Line Items]
Additional borrowing capacity			$ 35,000,000
Borrowing available start date			Jun. 15, 2025
Borrowing available end date			Jun. 15, 2026
Loan Agreement | Term Loan Fifth Tranche | Hercules | Prior To January 1, 2026
Debt Instrument [Line Items]
Additional borrowing capacity			$ 50,000,000
Warrants to Purchase Common Stock | Loan Agreement | Term Loan | Hercules
Debt Instrument [Line Items]
Common stock, par value (in dollars per share) | $ / shares							$ 0.0001
Maximum percentage of warrants purchased							1.50%